Literature DB >> 7416743

Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin.

G H Hottendorf, L L Gordon.   

Abstract

Most investigations of the comparative nephrotoxicities of aminoglycosides in animals have utilized large multiples of the human dose. Furthermore, many of these assessments have used only one or two dose levels and have not described a dose-response comparison among antibiotics. Because of this lack of comparative dose-response data over a range of low multiples of the human dose, the nephrotoxicities of gentamicin, tobramycin, and amikacin were investigated in 180 rats, utilizing doses ranging from one to seven times the equivalent human clinical doses. Histopathological evaluations of both kidneys from each rat were scored without knowledge of the treatment, and statistical analyses of the results indicated that a linear and parallel dose-response relationship existed for each drug, the relative nephrotoxicity over the range of doses analyzed was gentamicin > tobramycin > amikacin (P = 0.0001), and, unlike amikacin, the human dose equivalents (milligrams per kilogram) of gentamicin and tobramycin were significantly nephrotoxic in rats (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7416743      PMCID: PMC283960          DOI: 10.1128/AAC.18.1.176

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Blood urea nitrogen and serum creatinine. Physiology and interpretations.

Authors:  N Baum; C C Dichoso; C E Carlton
Journal:  Urology       Date:  1975-05       Impact factor: 2.649

2.  Enzymes of renal origin in urine as indicators of nephrotoxicity.

Authors:  W E Stroo; J B Hook
Journal:  Toxicol Appl Pharmacol       Date:  1977-03       Impact factor: 4.219

Review 3.  The cephalosporins--1973.

Authors:  W L Hewitt
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

4.  Preclinical toxicology studies with tobramycin.

Authors:  J S Welles; J L Emmerson; W R Gibson; R Nickander; N V Owen; R C Anderson
Journal:  Toxicol Appl Pharmacol       Date:  1973-07       Impact factor: 4.219

5.  Nephrotoxicity of gentamicin.

Authors:  J C Kosek; R I Mazze; M J Cousins
Journal:  Lab Invest       Date:  1974-01       Impact factor: 5.662

6.  Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia.

Authors:  J B Dossetor
Journal:  Ann Intern Med       Date:  1966-12       Impact factor: 25.391

7.  Renal damage caused by gentamicin: a study of the effects on renal morphology and urinary enzyme excretion.

Authors:  J M Wellwood; D Lovell; A E Thompson; J R Tighe
Journal:  J Pathol       Date:  1976-03       Impact factor: 7.996

8.  Comparative nephrotoxicity of gentamicin and tobramycin in rats.

Authors:  D N Gilbert; C Plamp; P Starr; W M Bennet; D C Houghton; G Porter
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

9.  Gentamicin nephrotoxicity. II. Physiological, biochemical and morphological effects of prolonged administration to rats.

Authors:  F E Cuppage; K Setter; P Sullivan; E J Reitzes; A O Melnykovych
Journal:  Virchows Arch B Cell Pathol       Date:  1977-06-24

10.  The use of urinary enzyme measurements to detect renal damage caused by nephrotoxic compounds.

Authors:  P J Wright; D T Plummer
Journal:  Biochem Pharmacol       Date:  1974-01-01       Impact factor: 5.858

View more
  10 in total

Review 1.  Aminoglycoside research 1975-1985: prospects for development of improved agents.

Authors:  K E Price
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

2.  Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.

Authors:  C L Bregman; P D Williams
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Correlation between renal membrane binding and nephrotoxicity of aminoglycosides.

Authors:  P D Williams; D B Bennett; C R Gleason; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.

Authors:  N Brion; J Barge; I Godefroy; F Dromer; C Dubois; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

5.  Nonparallel nephrotoxicity dose-response curves of aminoglycosides.

Authors:  G H Hottendorf; D Barnett; L L Gordon; E F Christensen; H Madissoo
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

6.  Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats.

Authors:  G Laurent; P Maldague; M B Carlier; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

7.  Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies.

Authors:  M B Carlier; G Laurent; P J Claes; H J Vanderhaeghe; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

Review 8.  What is the evidence for once-daily aminoglycoside therapy?

Authors:  M L Barclay; E J Begg; K G Hickling
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

9.  Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.

Authors:  Sophie Denamur; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

10.  Two-compartment comparison of gentamicin and tobramycin in normal volunteers.

Authors:  M Adelman; E Evans; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.